Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FLNC antisense RNA 1 (FLNC-AS1)
- Target
- FLNC-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Natural antisense transcript (NAT), Other (lncRNA regulatory RNA family)
01
Overview
FLNC antisense RNA 1 (FLNC-AS1) is a natural antisense long non-coding RNA transcribed from the opposite strand of the FLNC (filamin C) gene locus[3]. It belongs to the class of antisense lncRNAs that can regulate their overlapping sense genes or nearby genomic regions via RNA-RNA, RNA-DNA, or RNA-protein interactions[4]. The precise biological function of FLNC-AS1 remains to be fully elucidated, but, like other antisense lncRNAs, it may influence the transcription, stability, or translation of FLNC mRNA, potentially through epigenetic or post-transcriptional regulatory processes[3][4]. There is currently no evidence it is a direct therapeutic target nor are there any approved drugs or clinical diagnostic roles associated with this transcript. If further data regarding disease association or mechanism of action for FLNC-AS1 becomes available, that could clarify its potential as a biomarker or therapeutic target[3].
- Other names
- FLNC-AS1FLNC antisense RNA 1
02
Biological functions
Regulation of gene expression at the transcriptional or post-transcriptional levelPossible involvement in chromatin modification, RNA stability, or translation via antisense mechanisms (exact functional studies for FLNC-AS1 are limited, but these are common for antisense lncRNAs)
03
Disease associations
Other (Evidence for disease association is unclear and not currently classified in cancer, cardiovascular, or major disease categories based on available sources)
Beyond the preview
Go deeper on FLNC antisense RNA 1 (FLNC-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FLNC antisense RNA 1 (FLNC-AS1).